Take me to the text The following financial statements are taken from the records of Organo Inc. a) Use horizontal analysis techniques to compare the changes between 2020 and 2019 balance sheet items, Do not enter dollar signs or commas in the input boxes. Use the negative sign for negative values, Round all percentages to 2 decimal places. Organo Inc. Balance Sheet As at February 28 2020 2019 s Change % Change Current Assets Cash $310.600 $324,000 $ 9 $159,200 Accounts Receivable $191,600 $ 96 96 Merchandise Inventory $356,000 $387.500 $ 96 Short-Term Investments $127.000 $111.300 5 98 Total Current Assets 5952.800 $1.014,4005 96 Long-Term Assets $430,300 $310.900 S 96 Total Assets $1,383,100 $1.325.300 S 98 Current Liabilities $308,200 $266,6005 Current Liabilities $308.200 $266,600 $ Long-Term Liabilities $184.900 $93,300 $ Total Liabilities $443,100 $359,900 $ 96 Shareholders' Equity $940,000 $965.400 S %6 Total Liabilities and Equity $1,383,100 $1,325,300 $ %6 b) Perform a vertical analysis of the income statement for 2020. stating all income statement items as a percentage of net sales. Organo Inc. Income Statement For the Year Ended December 31 2020 Sales $701.000 96 $245,350 Cost of Goods Sold 96 $455.650 Gross Profit %6 Operating Expenses 26 Advertising Expense $3,400 % Utilities Expense $8,000 Gross Profit $455,650 % Operating Expenses Advertising Expense $3,400 % Utilities Expense $8,000 % Rent Expense $4,200 9 % Salaries and Wages Expense $45,400 $37.100 Depreciation Expense % $7,300 Interest Expense % $105,400 Total Expenses % % Income Before Income Tax $350,250 % Income Tax Expense $105,075 % Net Income $245,175